Exchange: NASDAQ·Updated 06:30 PM EST

About GNPX

About

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner on April 1, 2009 and is headquartered in Austin, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13

Frequently Asked Questions

Advertisement|Remove ads.